These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14512897)

  • 1. Prospective analysis of risk factors for hepatocellular carcinoma on patients with cirrhosis.
    Di Costanzo GG
    Hepatology; 2003 Oct; 38(4):1061; author reply 1061. PubMed ID: 14512897
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].
    Tarao K; Shimizu A; Okawa S; Tamai S
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1985-91. PubMed ID: 8586918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is follow up of hepatocellular carcinoma in patients with liver cirrhosis justified?].
    Prat F
    Gastroenterol Clin Biol; 1992; 16(11):910. PubMed ID: 1282892
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.
    Ciernik IF
    N Engl J Med; 1993 Dec; 329(25):1897; author reply 1897-8. PubMed ID: 8247051
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.
    Collazos J
    N Engl J Med; 1993 Dec; 329(25):1896-7; author reply 1897-8. PubMed ID: 7504208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening for hepatocellular carcinoma in cirrhotic patients].
    Beaugrand M
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kuzuya T; Nonogaki K; Shimizu J
    J Gastroenterol Hepatol; 2005 Jun; 20(6):963-5. PubMed ID: 15946154
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 10. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and hepatocellular carcinoma: grist for the mill.
    Sherman M
    Gastroenterology; 2009 Jan; 136(1):39-42. PubMed ID: 19041651
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma.
    Ahn J; Flamm SL
    Dis Mon; 2004 Oct; 50(10):556-73. PubMed ID: 15616490
    [No Abstract]   [Full Text] [Related]  

  • 14. Etiological factor of hepatocellular carcinoma in Italy.
    Stroffolini T
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis.
    Shimoda R; Nagashima M; Sakamoto M; Yamaguchi N; Hirohashi S; Yokota J; Kasai H
    Cancer Res; 1994 Jun; 54(12):3171-2. PubMed ID: 8205535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma. Unifying our efforts].
    Barbare JC
    Rev Prat; 2004 Mar; 54(6):587-90. PubMed ID: 15222607
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatocellular carcinoma in cirrhosis. The surgeon's point of view].
    Smadja C; Franco D
    Ann Gastroenterol Hepatol (Paris); 1989; 25(4):129-31. PubMed ID: 2548431
    [No Abstract]   [Full Text] [Related]  

  • 18. Confidence intervals for proportions--the Cinderella of statistical analyses.
    Newcombe RG
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):92-3. PubMed ID: 17931844
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatocellular carcinoma in childhood.
    McDougal RA
    Arch Pathol Lab Med; 1979 Aug; 103(9):489. PubMed ID: 223521
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.